Elite Pharmaceuticals, Inc.
ELTP
$0.551
$0.00350.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 92.11% | 36.44% | -13.21% | 13.65% | 18.31% |
| Total Receivables | 24.01% | 58.27% | -13.94% | 4.67% | 5.31% |
| Inventory | 19.19% | -19.43% | 42.31% | 2.41% | 6.97% |
| Prepaid Expenses | -43.89% | -14.70% | 777.84% | -70.07% | -16.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 34.85% | 20.17% | 6.08% | 4.94% | 7.86% |
|
|
|||||
| Total Current Assets | 34.85% | 20.17% | 6.08% | 4.94% | 7.86% |
| Net Property, Plant & Equipment | -2.06% | 1.68% | -2.88% | -3.34% | 1.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.12% | -15.03% | 0.75% | -4.35% | 3.09% |
| Total Assets | 15.51% | 6.20% | 2.90% | 0.40% | 5.01% |
|
|
|||||
| Total Accounts Payable | 72.06% | -49.36% | 194.48% | -23.92% | -3.95% |
| Total Accrued Expenses | 10.82% | 7.52% | -39.18% | -4.46% | 14.80% |
| Short-term Debt | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.71% | -3.44% | -2.96% | -0.98% | 14.29% |
| Total Finance Division Other Current Liabilities | 118.26% | -32.75% | 18.86% | -39.21% | 42.85% |
| Total Other Current Liabilities | 118.26% | -32.75% | 18.86% | -39.21% | 42.85% |
| Total Current Liabilities | -9.10% | -19.39% | 14.28% | -8.28% | 7.39% |
|
|
|||||
| Total Current Liabilities | -9.10% | -19.39% | 14.28% | -8.28% | 7.39% |
| Long-Term Debt | -0.63% | -0.63% | -0.77% | -5.19% | -1.07% |
| Short-term Debt | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Capital Leases | -8.16% | -6.82% | -5.08% | -2.68% | -5.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 87.74% | -24.92% | 53.72% | 140.40% | 44.09% |
| Total Liabilities | 48.48% | -21.06% | 32.69% | 38.30% | 13.52% |
|
|
|||||
| Common Stock & APIC | 0.03% | 0.04% | 0.04% | 0.03% | 0.03% |
| Retained Earnings | -4.88% | 12.34% | -8.59% | -9.53% | 0.53% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -10.90% | 46.83% | -22.89% | -18.86% | 1.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.90% | 46.83% | -22.89% | -18.86% | 1.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.90% | 46.83% | -22.89% | -18.86% | 1.16% |
|
|
|||||